BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A

Upper Limb ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Clinical Effectiveness ◽

Botulinum Toxin Type ◽

Limb Spasticity ◽

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A

Health Technology Assessment ◽

10.3310/hta14260 ◽

2010 ◽

Vol 14 (26) ◽

Cited By ~ 92

Author(s):

L Shaw ◽

H Rodgers, ◽

C Price ◽

F van Wijck ◽

P Shackley ◽

...

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Upper Limb ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Clinical Effectiveness ◽

Botulinum Toxin Type ◽

Limb Spasticity ◽

Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A

Trials ◽

10.1186/1745-6215-9-59 ◽

2008 ◽

Vol 9 (1) ◽

Cited By ~ 11

Author(s):

Helen Rodgers ◽

◽

Lisa Shaw ◽

Christopher Price ◽

Frederike van Wijck ◽

...

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Clinical Effect ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Botulinum Toxin Type ◽

Limb Spasticity ◽

Randomised Controlled ◽

Design And Methods

271 A randomised controlled trial to evaluate the efficacy of botulinum toxin type A in the treatment of patients suffering bladder pain syndrome/interstitial cystitis with Hunner's lesions: Preliminary results

European Urology Supplements ◽

10.1016/s1569-9056(12)60268-1 ◽

2012 ◽

Vol 11 (1) ◽

pp. e271-e271a ◽

Cited By ~ 1

Author(s):

A.V. Zaitcev ◽

G.R. Kasyan ◽

O. Tsibulya ◽

D.Y. Pushkar

Keyword(s):

Botulinum Toxin ◽

Interstitial Cystitis ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Pain Syndrome ◽

Botulinum Toxin Type ◽

Bladder Pain Syndrome ◽

Bladder Pain ◽

Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial

Toxins ◽

10.3390/toxins4121415 ◽

2012 ◽

Vol 4 (12) ◽

pp. 1415-1426 ◽

Cited By ~ 6

Author(s):

Phil Shackley ◽

Lisa Shaw ◽

Christopher Price ◽

Frederike Wijck ◽

Michael Barnes ◽

...

Keyword(s):

Botulinum Toxin ◽

Cost Effectiveness ◽

Upper Limb ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Limb Spasticity

Remote central effects of botulinum toxin type A as adjuvant to intense occupational therapy in the early stage of stroke: A Type II fMRI randomised controlled trial

Toxicon ◽

10.1016/j.toxicon.2020.11.406 ◽

2021 ◽

Vol 190 ◽

pp. S33

Author(s):

Jorge Hernández-Franco ◽

Felipe Orihuela-Espina ◽

Lorena Palafox ◽

Chanel Palencia ◽

Cecilia Camberos-Angulo ◽

...

Keyword(s):

Botulinum Toxin ◽

Occupational Therapy ◽

Early Stage ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Botulinum Toxin Type ◽

Type Ii ◽

Central Effects ◽

Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation

Zhurnal nevrologii i psikhiatrii im S S Korsakova ◽

10.17116/jnevro202112111139 ◽

2021 ◽

Vol 121 (11) ◽

pp. 39

Author(s):

S.E. Khat’kova ◽

A. Baikova ◽

P. Maisonobe ◽

D.R. Khasanova

Keyword(s):

Cohort Study ◽

Botulinum Toxin ◽

Upper Limb ◽

Goal Attainment ◽

Botulinum Toxin Type A ◽

Real Life ◽

Type A ◽

Botulinum Toxin Type ◽

Limb Spasticity

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke

Stroke ◽

10.1161/01.str.31.10.2402 ◽

2000 ◽

Vol 31 (10) ◽

pp. 2402-2406 ◽

Cited By ~ 190

Author(s):

A. M. O. Bakheit ◽

A. F. Thilmann ◽

A. B. Ward ◽

W. Poewe ◽

J. Wissel ◽

...

Keyword(s):

Botulinum Toxin ◽

Upper Limb ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Limb Spasticity ◽

Dose Ranging

A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)

Trials ◽

10.1186/1745-6215-15-14 ◽

2014 ◽

Vol 15 (1) ◽

Cited By ~ 50

Author(s):

Athimalaipet V Ramanan ◽

◽

Andrew D Dick ◽

Diana Benton ◽

Sandrine Compeyrot-Lacassagne ◽

...

Keyword(s):

Juvenile Idiopathic Arthritis ◽

Cost Effectiveness ◽

Controlled Trial ◽

Clinical Effectiveness ◽

Comparing the clinical-effectiveness and cost-effectiveness of an internet-delivered Acceptance and Commitment Therapy (ACT) intervention with a waiting list control among adults with chronic pain: study protocol for a randomised controlled trial

BMJ Open ◽

10.1136/bmjopen-2014-005092 ◽

2014 ◽

Vol 4 (7) ◽

pp. e005092-e005092 ◽

Cited By ~ 8

Author(s):

S. Hayes ◽

M. Hogan ◽

H. Dowd ◽

E. Doherty ◽

S. O'Higgins ◽

...

Keyword(s):

Chronic Pain ◽

Cost Effectiveness ◽

Acceptance And Commitment Therapy ◽

Study Protocol ◽

Controlled Trial ◽

Clinical Effectiveness ◽

Waiting List ◽

Acceptance And Commitment ◽

Treatment of Upper Limb Spasticity after Stroke: One-Year Safety and Efficacy of Botulinum Toxin Type A NT201

International Journal of Immunopathology and Pharmacology ◽

10.1177/03946320120250s109 ◽

2012 ◽

Vol 25 (1_suppl) ◽

pp. 57-62 ◽

Cited By ~ 3

Author(s):

P. Fiore ◽

A. Santamato ◽

M. Ranieri ◽

R.G. Bellomo ◽

R. Saggini ◽

...

Keyword(s):

Botulinum Toxin ◽

Upper Limb ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Safety And Efficacy ◽

Limb Spasticity ◽

One Year